2025年9月21日盘后，环球印务发布了关于持股5%以上股东减持公司股份的预披露公告。该公告显示，自本公告发布之日起15个交易日后的 三个月内（即2025年10月22日至2026年1月21日），股东香港原石国际有限公司（以下简称"香港原石"）计划以集中竞价交易合计减持不超 过320.04万股公司股份，占公司总股本比例的1%。香港原石本次拟减持的原因为自身资金需要，减持的股份来源为首次公开发行前已发行 股份。 | 股东姓名 | 股东身份 | 持有公司股 | 占公司总股 | 拟减持股份 数量(股〈不 | 拟减持股份数 量占公司总股 | | --- | --- | --- | --- | --- | --- | | | | 份数量(股) | 本比例 | | | | | | | | 超过》) | 本的比例 | | 香港原石国际有限 | 持股 5%以上 | 35, 134, 040 | 10. 98% | 3, 200, 400 | 1% | | 公司 | 股东 | | | | | （图片来源：截图自环球印务公告） 香港原石在2025年6月份就已经减持套现约2659.53万元。根据环球印务2025年6月份发布的关于持股 ...

Core Viewpoint - The recent mid-year report for 2025 from Global Printing (002799) indicates significant declines in revenue and profit, primarily due to a contraction in the internet digital marketing business and increased management costs [2][14]. Business Overview - As of the reporting period, the total operating revenue was 439 million yuan, a year-on-year decrease of 43.53% [2]. - The net profit attributable to shareholders was -3.72 million yuan, down 109.85% year-on-year [2]. - The second quarter alone saw an operating revenue of 201 million yuan, a decline of 38.6% year-on-year [2]. Financial Metrics Analysis - The gross profit margin for the mid-year report was 16.48%, an increase of 12.38% year-on-year [3]. - The net profit margin was -1.03%, a decrease of 120.53% year-on-year [3]. - Earnings per share were -0.01 yuan, down 108.33% year-on-year [3]. Cost and Expenses - Total operating expenses (selling, administrative, and financial expenses) amounted to 50.56 million yuan, representing 11.52% of revenue, an increase of 105.42% year-on-year [4]. - Administrative expenses rose by 37.8%, primarily due to increased wages and salaries during the reporting period [4]. Main Business Composition - Revenue from the pharmaceutical and other paper box business was 212 million yuan, accounting for 48.31% of total revenue, with a gross margin of 20.64% [5]. - The printing and packaging supply chain business generated 158 million yuan, making up 35.90% of total revenue, with a gross margin of 15.07% [6]. - Internet digital marketing contributed 66.03 million yuan, representing 15.04% of total revenue, with a gross margin of 3.00% [7]. - Other business segments generated 3.27 million yuan, accounting for 0.75% of total revenue, with a gross margin of 86.71% [8]. Regional Distribution - Revenue from the North China region was 154 million yuan, accounting for 35.15% of total revenue, with a gross margin of 15.55% [9]. - The Central South region contributed 114 million yuan, representing 26.08% of total revenue, with a gross margin of 13.68% [10]. - The East China region generated 91.34 million yuan, making up 20.81% of total revenue, with a gross margin of 14.80% [11]. - Revenue from Northwest, Northeast, Southwest regions, and overseas sales were 36.71 million yuan, 24.38 million yuan, 13.81 million yuan, and 3.93 million yuan, respectively [13]. Operational Commentary - The decline in operating revenue is primarily attributed to the contraction in the internet digital marketing business, alongside increased management costs and overdue accounts receivable [14]. - Despite these challenges, the company maintains a competitive edge in the pharmaceutical and consumer packaging sectors and continues to optimize resource allocation to enhance overall efficiency [14]. Core Competitiveness Analysis - The company possesses advantages in brand and customer resources, manufacturing, innovation, management, and safety and environmental protection in the pharmaceutical packaging business [15]. - In the printing and packaging supply chain management sector, the company has advantages in industry resource integration, customer resources, R&D and technical services, and talent [15]. Financial Health Status - The company has a healthy cash asset position, but attention is needed on cash flow, with the average operating cash flow over the past three years being 15.09% of current liabilities [16].

Performance Forecast - The company expects a net loss attributable to shareholders of between 3.5 million and 6 million yuan, compared to a profit of 37.75 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is expected to be a loss of 5 million to 8 million yuan, down from a profit of 36.73 million yuan in the previous year [1] - Basic earnings per share are projected to be a loss of 0.01 to 0.02 yuan per share, compared to earnings of 0.12 yuan per share last year [1] Communication with Auditors - The financial data in this performance forecast has not been audited by the accounting firm, but the company has communicated with the auditors regarding the forecast, and there are no discrepancies [1] Reasons for Performance Change - The decline in net profit attributable to shareholders and the net profit after deducting non-recurring gains and losses is primarily due to increased costs from the new factory in the pharmaceutical and other paper box businesses, as well as intensified market competition leading to a decrease in gross margin [1] - The contraction in the internet digital marketing business has also impacted overall performance [1]